FDA Overhauls Opioid Painkiller Labels, Urging Careful Use
After years of wrenching debate, the U.S. Food and Drug Administration on Tuesday announced labeling revisions that will recommend doctors prescribe extended-release opioid painkillers, such as Purdue Pharma LP's Oxycontin and...To view the full article, register now.
Already a subscriber? Click here to view full article